Apr 2
Registration statement
S-3/A
Registration statement
ENVB · Enveric Biosciences, Inc. · Documents
$1.52
+0.03 (+2.01%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these unaudited condensed consolidated financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.80M
Shares
4.48M
Volume · Nov 12
32.25K
Avg daily vol (3M)
71.41K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2021
Apr 1
Current report
8-K
Financial results
Apr 1
Apr 1
Late filing notice
NT 10-K
Late filing notice
Mar 23
Current report
8-K
Events of Mar 17
Director or officer change, or executive pay
Mar 19
Proxy statement
PRE 14A
Proxy statement
Mar 11
Current report
8-K
Events of Mar 5
Entered into a material agreement, Other events
Feb 26
Current report
8-K
Events of Feb 22
Entered into a material agreement, Other events
Feb 16
Registration statement
S-3
Registration statement
Feb 12
Current report
8-K
Other events
Feb 11
Current report
8-K
Events of Feb 9
Entered into a material agreement, Unregistered sale of equity, Other events
Feb 9
Current report
8-K/A
Events of Dec 30
Current report
Jan 15
Current report
8-K
Other events
Jan 13
Current report
8-K/A
Events of Jan 12
Current report
Jan 12
Current report
8-K
Events of Jan 11
Entered into a material agreement, Unregistered sale of equity, Other events
Jan 11
Current report
8-K/A
Events of Dec 30
Current report
Jan 6
Current report
8-K
Events of Dec 30
Entered into a material agreement, Completed an acquisition or sale of assets, Unregistered sale of equity, Change to shareholders' rights, Change in control, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events
Jan 6
Current report
8-K
Events of Dec 30
Delisting notice or listing transfer, Change of auditor, Regulation FD disclosure
2020
Dec 29
Current report
8-K
Shareholder vote results, Other events
Dec 23
Current report
8-K
Other events
Dec 18
Current report
8-K
Entered into a material agreement, Other events
Dec 15
Current report
8-K
Shareholder vote results
Nov 16
Quarterly report
10-Q
FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $8.48M
▼ 7.3%
Net loss $961.17K
Diluted EPS -$0.20
Nov 10
Registration statement
S-4/A
Registration statement
Nov 9
Registration statement
S-4/A
Registration statement
Nov 4
Proxy statement
DEF 14A
Proxy statement
Oct 22
Registration statement
S-4/A
Registration statement
Sep 17
Registration statement
S-4/A
Registration statement
Sep 16
Current report
8-K/A
Events of Sep 15
Entered into a material agreement, Unregistered sale of equity
Sep 11
Current report
8-K
Events of Sep 10
Entered into a material agreement
Aug 14
Quarterly report
10-Q
FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $8.25M
▼ 25.1%
Net loss $1.57M
Diluted EPS -$0.48
Aug 12
Annual report
10-K/A
FY2019, ended Dec 31
Annual report for FY2019
Revenue $39.91M
▼ 7.2%
Net loss $5.61M
Diluted EPS -$2.83
Aug 12
Current report
8-K
Entered into a material agreement
Aug 12
Registration statement
S-4/A
Registration statement
Aug 3
Current report
8-K
Events of Jul 31
Entered into a material agreement, Unregistered sale of equity
Jun 4
Current report
8-K
Events of Jun 2
Entered into a material agreement, Unregistered sale of equity, Other events
Jun 1
Current report
8-K
Events of May 26
Entered into a material agreement
May 28
Registration statement
S-4
Registration statement
May 15
Quarterly report
10-Q
FY2020 Q1, ended Mar 31
Quarterly report for FY2020 Q1
Revenue $9.6M
▼ 10.1%
Net loss $1.78M
Diluted EPS -$0.60
May 6
Mar 25
Annual report
10-K
FY2019, ended Dec 31
Annual report for FY2019
Revenue $39.91M
▼ 7.2%
Net loss $5.6M
Diluted EPS -$2.83
Mar 4
Current report
8-K
Events of Feb 27
Entered into a material agreement, New debt or off-balance-sheet obligation
Jan 13
Current report
8-K
Events of Jan 10
Entered into a material agreement, Unregistered sale of equity, Other events
Showing 201–243 of 243 documents
Key facts
CIK
890821
CUSIP
29405E505
13F (30d)
16 filings
12 filers
Visit website
Investor relations